AP2006003703A0 - Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent - Google Patents

Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent

Info

Publication number
AP2006003703A0
AP2006003703A0 AP2006003703A AP2006003703A AP2006003703A0 AP 2006003703 A0 AP2006003703 A0 AP 2006003703A0 AP 2006003703 A AP2006003703 A AP 2006003703A AP 2006003703 A AP2006003703 A AP 2006003703A AP 2006003703 A0 AP2006003703 A0 AP 2006003703A0
Authority
AP
ARIPO
Prior art keywords
pharmaceutical compositions
proton pump
pump inhibitor
prokinetic agent
prokinetic
Prior art date
Application number
AP2006003703A
Other languages
English (en)
Inventor
Sukhjeet Singh
Rajesh Jain
Kour Chand Jindal
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of AP2006003703A0 publication Critical patent/AP2006003703A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AP2006003703A 2004-01-06 2005-01-05 Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent AP2006003703A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN21DE2004 2004-01-06
IN25DE2004 2004-01-06
PCT/IN2005/000002 WO2005065664A1 (en) 2004-01-06 2005-01-05 Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent

Publications (1)

Publication Number Publication Date
AP2006003703A0 true AP2006003703A0 (en) 2006-08-31

Family

ID=34751863

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2006003703A AP2006003703A0 (en) 2004-01-06 2005-01-05 Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent

Country Status (11)

Country Link
US (1) US20070160664A1 (sr)
EP (1) EP1729743A1 (sr)
AP (1) AP2006003703A0 (sr)
AU (1) AU2005204014B2 (sr)
BR (1) BRPI0506704A (sr)
CA (1) CA2552627A1 (sr)
EA (1) EA012261B1 (sr)
NZ (1) NZ548780A (sr)
RS (1) RS20050796A (sr)
WO (1) WO2005065664A1 (sr)
ZA (1) ZA200606409B (sr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
JP5474541B2 (ja) * 2006-07-25 2014-04-16 ベクタ・リミテッド 小さいジカルボン酸の誘導体と組み合わせてppiを用いる胃酸分泌を阻害する組成物および方法
EP2644618B1 (en) 2007-02-09 2016-08-17 Ocera Therapeutics, Inc. tether intermediates for the synthesis of macrocyclic ghrelin receptor modulators
WO2010038241A2 (en) * 2008-09-30 2010-04-08 Panacea Biotec Limited Pharmaceutical compositions comprising of proton pump inhibitor, prokinetic agent and alginic acid
EP2563341A1 (en) * 2010-04-26 2013-03-06 Mahmut Bilgic Pharmaceutical compositions inducing synergistic effect
JPWO2012018056A1 (ja) * 2010-08-03 2013-10-03 エーザイ・アール・アンド・ディー・マネジメント株式会社 圧縮組成物
BRPI1103093A2 (pt) * 2011-06-03 2013-07-02 Eurofarma Laboratarios Ltda composiÇço farmacÊutica oral e uso da composiÇço farmacÊutica oral
KR20130024644A (ko) * 2011-08-31 2013-03-08 한국유나이티드제약 주식회사 이토프라이드 염산염을 함유하는 제어 방출성 경구 제제의 조성물 및 그의 제조방법
US11000481B2 (en) 2015-06-26 2021-05-11 Korea United Pharm. Inc. Composite preparation of mosapride and rabeprazole
WO2024042540A1 (en) * 2022-08-24 2024-02-29 Alkem Laboratories Limited Mesdopetam compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08512322A (ja) * 1993-07-06 1996-12-24 メルク エンド カンパニー インコーポレーテッド H▲下2▼拮抗剤−胃腸運動性の薬剤組合せ物
SE9600072D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
JP2001507359A (ja) * 1997-01-03 2001-06-05 エラン コーポレーション ピーエルシー 徐放性シサプリドミニ錠剤製剤
US6521255B2 (en) * 2000-01-13 2003-02-18 Osmotica Corp. Osmotic device containing ranitidine and a prokinetic agent
EP1596838A2 (en) * 2003-02-11 2005-11-23 Torrent Pharmaceuticals Ltd Once a day orally administered pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent

Also Published As

Publication number Publication date
US20070160664A1 (en) 2007-07-12
WO2005065664A8 (en) 2005-10-20
CA2552627A1 (en) 2005-07-21
WO2005065664A1 (en) 2005-07-21
AU2005204014B2 (en) 2008-02-28
EA012261B1 (ru) 2009-08-28
ZA200606409B (en) 2008-06-25
RS20050796A (en) 2007-08-03
AU2005204014A1 (en) 2005-07-21
BRPI0506704A (pt) 2007-05-02
NZ548780A (en) 2008-09-26
EP1729743A1 (en) 2006-12-13
EA200601286A1 (ru) 2007-02-27

Similar Documents

Publication Publication Date Title
EP1742630A4 (en) COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND PROKINETIC AGENT
PT2319308T (pt) Combinações de substâncias ativas fungicidas contendo fluoxastrobina e uma outra substância ativa fungicida
EP1803709A4 (en) PROTON PUMP INHIBITORS
IL186944A (en) Solid formulation of laxative and various aspects related to this formulation
IL183658A0 (en) Solid dosage form comprising proton pump inhibitor and suspension made thereof
GB0413730D0 (en) A pharmaceutical composition and its use
IL179795A0 (en) A pharmaceutical composition and its use
IL178417A0 (en) Pharmaceutical compositions comprising a jnk inhibitor and cyclosporin
EP1887008A4 (en) THIENOTRIAZOLODIAZEPINE COMPOUND AND A MEDICAL APPLICATION THEREOF
HK1121372A1 (en) Formulation comprising metformin and vildagliptin
PL1973423T3 (pl) Preparat zawierający kompozycję zawierającą polifenole i izomaltulozę
IL183986A0 (en) Pharmaceutical compounds and compositions
ZA200703148B (en) Pharmaceutical compositions comprising a camtothecin derivate
IL213897A0 (en) Ultrasound contrast agent dosage formulation
IL199904A0 (en) Compositions comprising a therapeutic agent and an alkoxy-polyethylene glycol and uses thereof
AP2006003703A0 (en) Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent
GB0413366D0 (en) Binder-free photopolymerizable compositions
ZA200700511B (en) A pharmaceutical composition comprising gabapentin
EP2015731A4 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY DRUG, ANTIPYRETIC AND ANALGESIC MEDICINE AND PROTON PUMP INHIBITOR
HK1172830A1 (en) Ultrasound contrast agent dosage formulation
IL178928A0 (en) Pharmaceutical compositions comprising zd6474
HU0401176D0 (en) Prokinetic pharmaceutical composition
TWI369980B (en) New association between agomelatine and a thymoregulatory agent and pharmaceutical compositions containing it
PL380070A1 (pl) Sposoby i kompozycje do doustnego podawania proleków inhibitorów pompy protonowej
EP1759703A4 (en) IMMUNOSTIMULATING AGENT AND INTERF ROGEN